Elastrin Therapeutics is a biotech company developing novel therapies to reverse cardiovascular disease.
Elastrin Therapeutics has raised $4.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2023.
Elastrin Therapeutics's investors include Starbloom Capital, KIZOO Technology Capital, SC Launch, Inc..
Elastrin Therapeutics is headquartered in Simpsonville, United States.
Elastrin Therapeutics is a biotech company developing novel therapies to reverse cardiovascular disease.
Elastrin Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Elastrin Therapeutics — Funding & Investors." VCBacked, November 3, 2023, https://www.vcbacked.co/company/elastrin-therapeutics. Accessed August 14, 2026.
VCBacked. (2023). Elastrin Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/elastrin-therapeutics
{{cite web |title=Elastrin Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/elastrin-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated